Last reviewed · How we verify
JMKX000197
At a glance
| Generic name | JMKX000197 |
|---|---|
| Sponsor | Jemincare |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion (PHASE1)
- A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- JMKX000197 CI brief — competitive landscape report
- JMKX000197 updates RSS · CI watch RSS
- Jemincare portfolio CI